Videssa Blood Test Improves Breast Cancer Detection in Post-menopausal Women, Study Shows

Videssa Blood Test Improves Breast Cancer Detection in Post-menopausal Women, Study Shows
Combining a new blood-based diagnostic test called Videssa Breast with breast imaging can improve breast cancer detection, reduce false diagnosis rates, and avoid unnecessary breast biopsies in women older than 50 with a moderate risk of cancer, according to a study. Provista Diagnostics, developer of Videssa Breast, announced the results of its latest study that clinically validates the test’s performance, suggesting its use could have avoided approximately 45% of biopsies in this age group. The study, “A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment,” was published in the journal Clinical Cancer Research. Tests that complement breast imaging are needed, particularly when clinical assessment is challenged by abnorm
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.